AGR2 and ERp44 loss-of-function experiments partially mimicked the effects of DDAs on cancer cells, and DDAs were found to disrupt disulfide-mediated AGR2 dimerization, as well as disulfide bonding between ERp44 or PDIA1 and their client proteins. The gene discussed is AGR2; the disease is cancer.